IDH1 and acute myeloid leukemia: The revolutionary discoveries and recent application of IDH1 and IDH2 inhibitors in the treatment of AML, although not directly targeted the mitochondrial structures, can still be considered in this light given the role of IDH isoforms in cellular metabolism [62,190].